156 results
Page 4 of 8
8-K
EX-99.1
24kk4knbj8k
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
8-K
EX-10.3
qdgpcwrfhb
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
8lr5xqi
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
50l309kq
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
hyqzdf
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
iinod6bp
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
qlv10 aa56
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
9dq2nm3
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
425
g4ukw ije
24 Jun 20
Business combination disclosure
4:03pm
425
vemw2
22 Jun 20
Business combination disclosure
5:30pm
8-K
EX-99.2
wknu0kte
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.3
6g744mp7yyuh7585
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.1
2p4zybe6ygegmsoi6
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm
8-K
EX-99.4
307ez 6irv17nx3z53mo
22 Jun 20
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
4:55pm